- Home
- CHY vs PRME Comparison
CHY vs PRME Comparison
Compare CHY & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHY
- PRME
- Stock Information
- Founded
- CHY 2003
- PRME 2019
- Country
- CHY United States
- PRME United States
- Employees
- CHY N/A
- PRME N/A
- Industry
- CHY Investment Managers
- PRME Medicinal Chemicals and Botanical Products
- Sector
- CHY Finance
- PRME Health Care
- Exchange
- CHY Nasdaq
- PRME Nasdaq
- Market Cap
- CHY 839.8M
- PRME 693.5M
- IPO Year
- CHY N/A
- PRME 2022
- Fundamental
- Price
- CHY $11.47
- PRME $6.45
- Analyst Decision
- CHY
- PRME Buy
- Analyst Count
- CHY 0
- PRME 6
- Target Price
- CHY N/A
- PRME $8.88
- AVG Volume (30 Days)
- CHY 128.3K
- PRME 4.0M
- Earning Date
- CHY 01-01-0001
- PRME 11-11-2025
- Dividend Yield
- CHY 10.11%
- PRME N/A
- EPS Growth
- CHY N/A
- PRME N/A
- EPS
- CHY N/A
- PRME N/A
- Revenue
- CHY N/A
- PRME $4,961,000.00
- Revenue This Year
- CHY N/A
- PRME $179.58
- Revenue Next Year
- CHY N/A
- PRME N/A
- P/E Ratio
- CHY N/A
- PRME N/A
- Revenue Growth
- CHY N/A
- PRME 739.42
- 52 Week Low
- CHY $9.97
- PRME $1.11
- 52 Week High
- CHY $12.16
- PRME $6.94
- Technical
- Relative Strength Index (RSI)
- CHY 64.81
- PRME 62.68
- Support Level
- CHY $11.26
- PRME $5.66
- Resistance Level
- CHY $11.45
- PRME $6.94
- Average True Range (ATR)
- CHY 0.10
- PRME 0.46
- MACD
- CHY 0.00
- PRME 0.04
- Stochastic Oscillator
- CHY 84.37
- PRME 52.37
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.